GMP News and Research

RSS

Pharmatek receives U.S. DEA approval for Schedule I-V controlled substance analysis

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has been approved by the United States Drug Enforcement Agency for the analysis of Schedules I through V controlled substances, complementing its existing license to develop and manufacture drug products containing Schedules IV and V controlled substances.

18 Apr 2011

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

Vitamins, herbs and other dietary supplements are sold as natural alternatives to pharmaceuticals and many people turn to them in an attempt to improve their health. Others seek supplements to lose weight or after hearing that they can help with serious medical conditions.

7 Apr 2011

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its fourth quarter and full year financial results periods ended December 31, 2010.

31 Mar 2011

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2010.

29 Mar 2011

China-Biotics supplies additional 3 new strain formulas to Bright Dairy

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced that the Company has expanded its categories of strain formula supplied to Bright Dairy.

17 Mar 2011

Finesse releases T700 upstream processing platform for single-use bioreactors

Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.

16 Mar 2011

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its fourth quarter and the fiscal year ended December 31, 2010.

15 Mar 2011

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Celerion, the premier provider of innovative early stage drug development solutions, announces the completion of a Clean Room and pharmacist certification to comply with USP 797 guidelines.

3 Mar 2011

Golden Meditech to acquire remaining shares in Chinese herbal medicine business for HK$90 million

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.

25 Feb 2011

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

EMA publishes concept paper on pharmaceutical cold storage conditions during transport

The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.

From IQPC Ltd 17 Feb 2011

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

8 Feb 2011

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Almac's new 240,000 sq. ft. North American Headquarters, built on 40 acres in Souderton, PA, north of Philadelphia is part of the Almac Group's integrated services solutions strategy. The new facility delivers full-service, integrated clinical packaging, drug supply management and technology solutions to pharmaceutical and biotech clients.

8 Feb 2011

Particle Sciences announces strategic alliance with HORIBA Instruments

Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.

8 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

Lotus adds two additional stories to new Beijing headquarters building

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced that it will add two additional stories to its new headquarters building in Chaoyang District, Beijing, which is currently under construction and is scheduled to be completed in the second quarter of 2011.

5 Feb 2011

Jungle Brolly launches new natural line of non alcoholic industrial hand sanitizers

Natural hand sanitizers prove a viable alternative to chemical-based hand sanitizers. In today's world, we are surrounded by a multitude of bacteria, germs, and viruses, as well as stories of new strains of those viruses, leading to serious illnesses and, in some cases, even death. In response, we seek convenient and more effective ways to protect ourselves.

4 Feb 2011

AMRI's Burlington facility granted AIFA approval to manufacture octreotide

AMRI announced today that it has received approval from the Italian Medicines Agency (AIFA) for its facility in Burlington, MA to manufacture the commercial drug product octreotide for a customer in the European Union (EU).

4 Feb 2011

DKMA issues GMP certificate to Cambrex Zenara Indian manufacturing facility

Cambrex Corporation announced today that the Danish Medicines Agency (DKMA) has issued a Certificate of Good Manufacturing Practice (GMP) compliance for its manufacturing site in Hyderabad, India, following an audit conducted in October 2010. The DKMA Certificate is accepted by all EU Health Authorities and by authorities of several other countries that recognize EU Certification.

18 Jan 2011

FDA stops operations of N.Y.-based beverage company

At the request of the U.S. Food and Drug Administration, the U.S. Department of Justice today filed a complaint for permanent injunction against a Jamaica, N.Y.-based beverage company to prevent it from processing and distributing juice and other products.

14 Jan 2011

GMP News and Research

Pharmatek receives U.S. DEA approval for Schedule I-V controlled substance analysis

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

Sinovac reports fourth quarter net sales of $9.1 million

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

China-Biotics supplies additional 3 new strain formulas to Bright Dairy

Finesse releases T700 upstream processing platform for single-use bioreactors

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Golden Meditech to acquire remaining shares in Chinese herbal medicine business for HK$90 million

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

EMA publishes concept paper on pharmaceutical cold storage conditions during transport

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Particle Sciences announces strategic alliance with HORIBA Instruments

AMRI fourth quarter total revenue increases 12% to $48.6 million

Lotus adds two additional stories to new Beijing headquarters building

Jungle Brolly launches new natural line of non alcoholic industrial hand sanitizers

AMRI's Burlington facility granted AIFA approval to manufacture octreotide

DKMA issues GMP certificate to Cambrex Zenara Indian manufacturing facility

FDA stops operations of N.Y.-based beverage company

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News